drugset
drugset / Trial / NCT00457197

Quetiapine for Bipolar Disorder and Alcohol Dependence

NCT00457197 ↗

Phase 4 Completed 90 enrolled University of Texas Southwestern Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to find out whether an investigational drug called quetiapine can treat bipolar disorder, improve mood and reduce alcohol use and craving.

Timeline

Start
2007-03
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Quetiapine Small molecule 600 mg —

Indications

alcohol dependence bipolar disorder